BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38197491)

  • 1. ABHD6 suppresses colorectal cancer progression via AKT signaling pathway.
    Xiong X; Yang C; Jin Y; Zhang R; Wang S; Gan L; Hou S; Bao Y; Zeng Z; Ye Y; Gao Z
    Mol Carcinog; 2024 Apr; 63(4):647-662. PubMed ID: 38197491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway.
    Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X
    Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of long non-coding RNA RP11-708H21.4 is associated with poor prognosis for colorectal cancer and promotes tumorigenesis through regulating AKT/mTOR pathway.
    Sun L; Jiang C; Xu C; Xue H; Zhou H; Gu L; Liu Y; Xu Q
    Oncotarget; 2017 Apr; 8(17):27929-27942. PubMed ID: 28427191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CHIP functions as an oncogene by promoting colorectal cancer metastasis via activation of MAPK and AKT signaling and suppression of E-cadherin.
    Xu J; Zhou J; Dai H; Liu F; Li W; Wang W; Guo F
    J Transl Med; 2018 Jun; 16(1):169. PubMed ID: 29921293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TMEM206 promotes the malignancy of colorectal cancer cells by interacting with AKT and extracellular signal-regulated kinase signaling pathways.
    Zhao J; Zhu D; Zhang X; Zhang Y; Zhou J; Dong M
    J Cell Physiol; 2019 Jul; 234(7):10888-10898. PubMed ID: 30417481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lycorine inhibits cell proliferation, migration and invasion, and primarily exerts
    Zhang P; Yuan X; Yu T; Huang H; Yang C; Zhang L; Yang S; Luo X; Luo J
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of PRDX6 Correlates with Migration and Invasiveness of Colorectal Cancer Cells.
    Huang WS; Huang CY; Hsieh MC; Kuo YH; Tung SY; Shen CH; Hsieh YY; Teng CC; Lee KC; Lee KF; Kuo HC
    Cell Physiol Biochem; 2018; 51(6):2616-2630. PubMed ID: 30562740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Berbamine dihydrochloride suppresses the progression of colorectal cancer via RTKs/Akt axis.
    Liu L; Liang D; Zheng Q; Zhao M; Lv R; Tang J; Chen N
    J Ethnopharmacol; 2023 Mar; 303():116025. PubMed ID: 36496042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of GLYR1 contributes to microsatellite instability colorectal cancer by targeting p21 via the p38MAPK and PI3K/AKT pathways.
    Hu Z; Long T; Ma Y; Zhu J; Gao L; Zhong Y; Wang X; Wang X; Li Z
    J Exp Clin Cancer Res; 2020 May; 39(1):76. PubMed ID: 32370786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KLF2 inhibits colorectal cancer progression and metastasis by inducing ferroptosis via the PI3K/AKT signaling pathway.
    Li J; Jiang JL; Chen YM; Lu WQ
    J Pathol Clin Res; 2023 Sep; 9(5):423-435. PubMed ID: 37147883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCL6B suppresses proliferation and migration of colorectal carcinoma cells through inhibition of the PI3K/AKT signaling pathway.
    Gu Y; Li A; Sun H; Li X; Zha H; Zhao J; Xie J; Zeng Z; Zhou L
    Int J Mol Med; 2018 May; 41(5):2660-2668. PubMed ID: 29393377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
    Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
    J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miRNA-495 suppresses proliferation and migration of colorectal cancer cells by targeting FAM83D.
    Yan L; Yao J; Qiu J
    Biomed Pharmacother; 2017 Dec; 96():974-981. PubMed ID: 29221726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid hormone receptor β1 suppresses proliferation and migration by inhibiting PI3K/Akt signaling in human colorectal cancer cells.
    Zhu L; Tian G; Yang Q; De G; Zhang Z; Wang Y; Nie H; Zhang Y; Yang X; Li J
    Oncol Rep; 2016 Sep; 36(3):1419-26. PubMed ID: 27431682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelial‑mesenchymal transition through PI3K/AKT signaling activation.
    Ji B; Feng Y; Sun Y; Ji D; Qian W; Zhang Z; Wang Q; Zhang Y; Zhang C; Sun Y
    Oncol Rep; 2018 Oct; 40(4):1885-1896. PubMed ID: 30066935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway.
    Zhang X; Xiong Y; Tang F; Bian Y; Chen Y; Zhang F
    Biomed Pharmacother; 2017 Dec; 96():877-883. PubMed ID: 29145164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
    Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z
    Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased expression of ARHGAP15 promotes the development of colorectal cancer through PTEN/AKT/FOXO1 axis.
    Pan S; Deng Y; Fu J; Zhang Y; Zhang Z; Ru X; Qin X
    Cell Death Dis; 2018 Jun; 9(6):673. PubMed ID: 29867200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
    Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
    J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ANLN, Regulated by SP2, Promotes Colorectal Carcinoma Cell Proliferation via PI3K/AKT and MAPK Signaling Pathway.
    Liu Y; Cao P; Cao F; Wang S; He Y; Xu Y; Wang Y
    J Invest Surg; 2022 Feb; 35(2):268-277. PubMed ID: 33757382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.